Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Deutsche Bank Downgrades MedAssets (MDAS) to Hold; Stepping to the Sidelines Following 4Q Miss and Reduced Guidance
-
Deutsche Bank Reinstates MedAssets (MDAS) at Buy; Growth Story Remains Attractive Despite More Conservative Outlook
-
Notable Analyst Rating Changes 08/18: MDAS, WFT, AGU, AEG Upgraded; NFLX, POT, CSCO, ITW Downgraded
-
Deutsche Bank Reiterates a 'Buy' Rating on MedAssets (MDAS); Add Shares at Current Levels
-
Notable Analyst Rating Changes for 12/9: S, MMM, CA, RNWK, NYX Upgraded; KR, ACN, LLL, LMT, RTN, MDAS Downgraded
-
Notable Analyst Rating Changes 9/1: MOT, RIMM, VALE, BHI, BHP, COH, LMT Upgraded; AIG, NOK, QCOM, ALU, AXL, VZ Downgraded
-
Notable Analyst Rating Changes 1/12: CFR, PALM, PFE Upgraded; AA, HOG, MDAS, BNI Downgraded
-
Notable Analyst Rating Changes 5/2: JWN, MDAS, EQ Upgraded; AIZ, GPS, JAVA Downgraded
-
Deutsche Bank Lowers Price Target on MedAssets (MDAS) But Maintains Buy
-
Notable Analyst Rating Changes 1/22: ABX, KSS, NMX, VLO Upgraded; DIS, AXP, JCP Downgraded
-
Deutsche Bank Starts MedAssets (MDAS) at Buy
